2026. Beyond Weight Loss: Practical Considerations for use of Glucagon like Peptide-1 (GLP-1) and Incretin Therapy in Inflammatory Skin Disease. Actualité dermatologique au Canada. 7, 3 (sept. 2026), 11–16. DOI:https://doi.org/10.58931/cdt.2026.73168.